Numinus Posts Revenue Surge for Fiscal 2023

The firm linked tighter margins to aggressive investment in full-time practitioners.

Numinus Wellness Inc. (OTCQX: NUMIF) reported a sharp rise in revenue for its fiscal year ended Aug. 31, buoyed by higher clinic appointments and a practitioner-friendly licensing model.

The company announced a 256.9% increase in revenue, driven by expanded services in North America and a rise in clinical trials. The growth resulted in a fourth-quarter revenue of $6.1 million, a 1.7% increase from the previous quarter and a 46.8% increase from the same quarter last year.

“In fiscal 2023, we built on the foundational work carried out in the previous year and continued to optimize synergies between our clinical, training and contract research management operations to provide the most comprehensive platform in the mental wellness space with a particular expertise in psychedelics,” founder and CEO Payton Nyquvest said in a statement.

“The results of our efforts can be seen in the increasing number of client visits, our research collaborations with leading drug developers and the growth of our training platform for practitioners. The anticipated approval of MDMA-assisted therapy by the FDA, if approved, will provide us with increased opportunities to deploy our unique service model using another treatment modality.”

The company expanded its training program for psychedelic practitioners and is enhancing its clinical research management services, he added.

Despite the positive trends, gross margin fell to 29.5% in the fourth quarter of 2023 from 34.5% in the previous quarter. The company linked the decline to a rise in full-time practitioners and varied clinic performances.

Numinus also implemented several cost-saving measures, including the closure of its underperforming clinic to focus resources on more profitable areas. The moves reduced operating expenditures to $7.9 million in the fourth quarter, down from $9.2 million in the previous quarter.

The company also successfully reduced its monthly cash burn to under $1 million as of October. Numinus reported a total cash balance of $8.6 million and working capital of $7.4 million.

Adam Jackson

Adam Jackson writes about the cannabis industry for the Green Market Report. He previously covered the Missouri Statehouse for the Columbia Missourian and has written for the Missouri Independent. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. You can find him on Twitter at @adam_sjackson and email him at adam.jackson@crain.com.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.